Angelini Pharma Bulgaria

Angelini Pharma Bulgaria, as a member of the pharmaceutical division of Angelini Industries is a Company with a leading position on the Bulgarian market, thanks to over the years outspreading successful strategies and maintaing positive development trend.

Angelini Pharma Bulgaria was established in 2007 with the acquisition of a group of pharmaceutical companies and few years later the ownership was transferred, that in 2013 set the beginning of Angelini Pharma Bulgaria EOOD.

As a member of a growing European Pharma Company, Angelini Pharma Bulgaria uses all possible opportunities to grow even more, to be competitive, to set up higher goals, to implement multinational know-how and thus all leading to the result of what we have become today – a Company with leading market positions and serious commitment to patients.

Angelini Pharma Bulgaria is amongst TOP 3 players in the field of Hepatitis C, non-steroidal anti-inflammatory drugs, maintains advantageous position in respiratory and pain treatment together with Consumer Healthcare Sore-throat market.

Company’s main goal is to be the natural choice for a healthy life and to offer people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. We aspire to become a leading European innovator and successfully develop distinctive treatments for Mental Health conditions, Epilepsy and Rare Diseases while selectively strengthening our leading position in the Consumer Healthcare segment.

We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies. Our Values determine our way of working and our Core Behaviors are the main driver for success.

Daily we are setting up stones towards becoming a leading European Pharma Company that makes a difference in patients’ life and delivers sustainable solutions for a better future.